Investment analysts at StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a report released on Friday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Trading Down 8.7 % TTNP stock opened at $6.29 on Friday. The business’s 50-day moving average is $6.93 and […]
Related Keywords
Canada , United States , , News Ratings For Titan Pharmaceuticals Daily , Institutional Investors Weigh In On Titan Pharmaceuticals , European Union , Renaissance Technologies , Titan Pharmaceuticals Inc , Virtu Financial , Titan Pharmaceuticals Trading Down , Titan Pharmaceuticals , Millennium Management , Get Free Report , Pharmaceuticals Trading Down , State Street Corp , Titan Pharmaceuticals Daily , Nasdaq Ttnp , Ttnp , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.